Synthace is a company based in the United Kingdom with one sole purpose in mind. The company wants to automate how biological laboratories are run and operate. This would allow the company to truly boost productivity but also allow places where people work with hazardous materials to reduce, or in the very least – outsource the compounds to machines.
Furthermore, the automation of laboratories could lead to logging test results 24/7, which will in turn increase private investment capital as it will mean quicker solutions. The company has been so exquisitely successful, with its latest funding round published in a press release on December 12.
Synthace managed to add $25.6 million in Series B funding which was led by Horizons Ventures, a venture capital fund. Many others joined, with Luminous Ventures, SOSV, and private investors. In the past, the company added Series A funding. The Series B funds amounted to $9.6 million, which is a respectable amount and no-less.
Synthace is banking on the future, in the words of its own CEO Tim Fell. The workflow of the future will be shared between machines and men, much like today, only computers will help do a lot more without human supervision. The in-house product developed by the company is called Antha and it allows biologists to carry out a range of operations, only this time they are fully automated to ensure that the scientists can work on different tasks.
The platform also ensures that safety mechanisms are put in check so as to guarantee the safety of everyone who uses the platform or trusts it to carry specific and potentially dangerous operations. Synthace understands how important and sensitive the data is and there is virtually no room for error.
This is what the company guarantees itself with Antha being completely error free in the words of the developers. The company has signed u with Dow AgroSciences, Merck & Co, GSK, and Fujifilm Diosynth and others, which is a significant recognition in the two years that Synthace has been around.
Synthace has much loftier goals for its company as well. The company wants to be the world’s leader in computer-aided technology, which will allow it to stand out from the crowd and shape itself as a leader in the delivery of specific operations that will boost productivity and lead to the next scientific breakthrough.
The world of science is changing rapidly and scientists are increasingly reliant on computers and proper record keeping to move forward, avoid errors and develop beyond all expectations. Achieving progress requires solid financial & technological backing.
Thankfully, Synthace combines both. The company has been recognized as one of the 30 most-promising companies in the world by the World Economic Forum (WEF). This is a recognition that has brought the company accolades, praise and most importantly – customers who trust Synthace to make their laboratories meet all necessary technological standards and tackle the challenges that today’s scientists experience. More investment will follow as Synthace continues to shape up the future of science.